- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed Myelodysplastic Syndromes
Total 81567 results
-
Asan Medical CenterPusan National University HospitalCompletedMyelodysplastic Syndromes | LeukemiaKorea, Republic of
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknownMyelodysplastic Syndromes | AdultBelgium, United States, Austria, United Kingdom, Italy, Taiwan, Brazil, China, Croatia, Czechia, France, Germany
-
Scios, Inc.CompletedMyelodysplastic Syndromes | Bone Marrow Diseases | Hematologic Diseases | Bone Marrow Neoplasms
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Myeloproliferative NeoplasmUnited States
-
Wolfson Medical CenterUnknownPrimary Myelofibrosis | Myelodysplastic SyndromeIsrael
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedMyelofibrosisUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myeloproliferative DiseasesUnited States
-
Washington University School of MedicineRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Whole Genome SequencingUnited States
-
M.D. Anderson Cancer CenterBayer; Celgene; Onyx Therapeutics, Inc.Completed
-
Centre Henri BecquerelUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance
-
M.D. Anderson Cancer CenterEisai Inc.CompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
Ryvu Therapeutics SARecruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic SyndromeItaly, Poland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid LeukemiaUnited States
-
Hemavant Sciences GmbHTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicKorea, Republic of, United States, Taiwan, Belgium, France, Spain, Italy
-
University of RochesterCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
Janssen Research & Development, LLCargenxWithdrawnMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited Kingdom, Switzerland, Italy, Germany, France, Spain, Australia, Turkey, Brazil, Russian Federation, Saudi Arabia
-
CelgeneCompletedLeukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeSpain
-
University Hospital, GrenobleCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaFrance
-
M.D. Anderson Cancer CenterEisai Inc.CompletedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsWithdrawnLeukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Boehringer IngelheimCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicJapan
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterEisai Inc.TerminatedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Sheba Medical CenterHadassah Medical Organization; Kaplan Medical Center; Tel Aviv Medical Center; Ziv...CompletedMyelodysplastic Syndrome With Low-grade Lesions | Iron Overload Due to Repeated Red Blood Cell TransfusionsIsrael
-
University of PittsburghWithdrawnAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Yale UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Leukemia Research FundCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Vion PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States, France, United Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host DiseaseUnited States
-
Temple UniversityCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Io TherapeuticsTerminatedAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States
-
Vion PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Graft Versus Host Disease | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States